We are live on ! Find out more
AS

Altshuler Shaham Portfolio holdings

AUM $8.04B
1-Year Est. Return 44.04%
This Fund
S&P 500
This Quarter Est. Return
+0.13%
1 Year Est. Return
+44.04%
3 Year Est. Return
+108.34%
5 Year Est. Return
+71.14%
10 Year Est. Return
AUM
$2.38B
AUM Growth
+$188M
Cap. Flow
+$189M
Cap. Flow %
7.96%
Top 10 Hldgs %
79.65%
Holding
417
New
125
Increased
152
Reduced
62
Closed
61

Sector Composition

Rank Sector Weight
1 Technology 31.7%
2 Consumer Discretionary 16.23%
3 Industrials 7.87%
4 Real Estate 4.08%
5 Healthcare 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENSG icon
276
The Ensign Group
ENSG
$10.6B
$11K ﹤0.01%
203
+29
+17% +$1.45K
EW icon
277
Edwards Lifesciences
EW
$53.4B
$11K ﹤0.01%
177
-150
-46% -$9.07K
EXEL icon
278
Exelixis
EXEL
$12.5B
$11K ﹤0.01%
+497
New +$10.4K
HOLX
279
DELISTED
Hologic
HOLX
$11K ﹤0.01%
226
+58
+35% +$2.68K
HSIC icon
280
Henry Schein
HSIC
$10B
$11K ﹤0.01%
153
+16
+12% +$1.06K
INCY icon
281
Incyte
INCY
$24.4B
$11K ﹤0.01%
125
-101
-45% -$8.11K
JNJ icon
282
Johnson & Johnson
JNJ
$632B
$11K ﹤0.01%
76
-59
-44% -$8.17K
MDT icon
283
Medtronic
MDT
$116B
$11K ﹤0.01%
108
+22
+26% +$2.01K
OMCL icon
284
Omnicell
OMCL
$1.72B
$11K ﹤0.01%
125
-102
-45% -$8.29K
PODD icon
285
Insulet
PODD
$10.2B
$11K ﹤0.01%
+91
New +$9.33K
QGEN icon
286
Qiagen
QGEN
$8.93B
$11K ﹤0.01%
251
+61
+32% +$2.53K
SYK icon
287
Stryker
SYK
$131B
$11K ﹤0.01%
55
-45
-45% -$8.59K
TMO icon
288
Thermo Fisher Scientific
TMO
$220B
$11K ﹤0.01%
38
+7
+23% +$1.93K
WST icon
289
West Pharmaceutical
WST
$24.4B
$11K ﹤0.01%
+88
New +$10.4K
PDCO
290
DELISTED
Patterson Companies, Inc.
PDCO
$11K ﹤0.01%
462
+100
+28% +$2.22K
HRC
291
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$11K ﹤0.01%
101
-80
-44% -$8.09K
INOV
292
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$11K ﹤0.01%
+724
New +$9.81K
ABBV icon
293
AbbVie
ABBV
$443B
$10K ﹤0.01%
+133
New +$10.5K
HLF icon
294
Herbalife
HLF
$1.28B
$10K ﹤0.01%
235
+96
+69% +$4.55K
IONS icon
295
Ionis Pharmaceuticals
IONS
$9.28B
$10K ﹤0.01%
155
+42
+37% +$2.97K
KIDS icon
296
OrthoPediatrics
KIDS
$653M
$10K ﹤0.01%
+254
New +$10.2K
LLY icon
297
Eli Lilly
LLY
$1.08T
$10K ﹤0.01%
87
-61
-41% -$7.18K
NEO icon
298
NeoGenomics
NEO
$2.11B
$10K ﹤0.01%
452
+32
+8% +$702
TECH icon
299
Bio-Techne
TECH
$11.2B
$10K ﹤0.01%
200
+36
+22% +$1.81K
ZBH icon
300
Zimmer Biomet
ZBH
$19B
$10K ﹤0.01%
+90
New +$10.5K

Similar funds

Altshuler Shaham's Q2 2019 Portfolio in Review

As of Q2 2019, Altshuler Shaham held 417 positions worth $2.38B, up 8.6% from $2.19B the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Altshuler Shaham deployed $189M of net new capital in Q2 2019, opening 125 new positions and adding to 152 existing holdings. Its largest new stake was F5: 9,774 shares worth $1.42M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Alibaba, an estimated $27.6M trimmed.

  • Altshuler Shaham's largest Q2 2019 buy was F5: 9,774 shares worth $1.42M.
  • Altshuler Shaham added most to Cisco in Q2 2019, an estimated $63.4M increase.
  • Altshuler Shaham's biggest Q2 2019 reduction was Alibaba, cutting an estimated $27.6M.
  • Altshuler Shaham fully exited Builders FirstSource in Q2 2019, selling an estimated $29.5M.
  • Altshuler Shaham's ten largest holdings make up 80% of its $2.38B portfolio in Q2 2019.
  • Altshuler Shaham opened 125 new positions and closed 61 in Q2 2019.
  • Altshuler Shaham's portfolio value rose 8.6% quarter-over-quarter to $2.38B.

Based on Altshuler Shaham's 13F filing for Q2 2019, filed 6 Aug 2019.